Login
$ANIX
$3.28 +$0.35 (11.95%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2026
As of Jul 31, 2026
Q2 FY2026
As of Apr 30, 2026
Q1 FY2026
As of Jan 31, 2026
Q4 FY2025
As of Oct 31, 2025
Q3 FY2025
As of Jul 31, 2025
Q2 FY2025
As of Apr 30, 2025
Q1 FY2025
As of Jan 31, 2025
Q4 FY2024
As of Oct 31, 2024
Q3 FY2024
As of Jul 31, 2024
Q2 FY2024
As of Apr 30, 2024
Q1 FY2024
As of Jan 31, 2024
Q4 FY2023
As of Oct 31, 2023
Q3 FY2023
As of Jul 31, 2023
Q2 FY2023
As of Apr 30, 2023
Q1 FY2023
As of Jan 31, 2023
Q4 FY2022
As of Oct 31, 2022
Q3 FY2022
As of Jul 31, 2022
Q2 FY2022
As of Apr 30, 2022
Q1 FY2022
As of Jan 31, 2022
Q4 FY2021
As of Oct 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Receivables
Prepaid expenses and other current assets
Total current assets
Operating lease right-of-use asset
Total assets
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Operating lease liability, current
Total current liabilities
Operating lease liability, non-current
Total liabilities
Equity:
Shareholders’ equity:
Common stock, par value $.01 per share; 100,000,000 shares authorized; 34,584,538 and 33,013,829 shares issued and outstanding as of July 31, 2026 and October 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, 2,000 shares at cost as of October 31, 2024
Total shareholders’ equity
Noncontrolling interest (Note 2)
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support